Welcome : Guest

Keryx Biopharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Keryx Biopharmaceuticals, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 28 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-06697
Price: $1400
Company Type: Public
Pages: 32
Date: November 2016
Market Data Tables: 28

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Biopharmaceuticals......4
Table 1: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......4
End-Stage Renal Disease (ESRD)......5
Table 2: End-Stage Renal Disease (ESRD) Cases by Age Group in the US (2015) - Percentage Share Breakdown for 45-64, 65-74, 75+, and Others......5
Table 3: End-Stage Renal Disease (ESRD) Cases by Diagnosis in the US (2015) - Percentage Share Breakdown by Value for Cystic Kidney, Diabetes, Glomerulonephritis, Hypertension, and Others......6
Table 4: End-Stage Renal Disease (ESRD) Market by Cause in China (2015) - Percentage Share Breakdown by Value for Diabetic Nephropathy, Glomerular Disease, Hypertension Caused Renal Disease and Others......7
Dialysis......8
Table 5: No. of Dialysis Patients by Category in China (2015) - Percentage Market Share Breakdown by Volume for Haemodialysis Patients, and Peritoneal Dialysis Patients......8
Table 6: Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, EPO alfa/beta biosimilars and Others......9
Table 7: Dialysis Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Dialysis Care, Dialysis Products......10
Table 8: No. of Dialysis Patients by Category Worldwide (2015) - Percentage Market Share Breakdown by Volume for Haemodialysis Patients, Peritoneal Dialysis Patients, and Transplant patients......11
Table 9: No. of Dialysis Patients by Geographic Region Worldwide (2015) - Percentage Share Breakdown for Europe, Japan, Rest of World (RoW), and USA......12
Table 10: No. of Dialysis Patients by Treatment Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Hemodialysis, and Peritoneal Dialysis......13
Table 11: No. of Dialysis Patients by Region Worldwide (2015) - Percentage Market Share Breakdown by Volume for Asia-Pacific, Europe, the Middle East and Africa (EMEA), Latin America, and North America......14
Table 12: Peritoneal Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Includes Mircera)......15
Table 13: Hemodialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others......16
Kidney Disease Drugs......17
Table 14: Traditional Chinese Medicine (TCM) Market for Kidney Ailments by Drug in China (2015) - Percentage Share Breakdown by Value Sales for Ambrette Capsule, Haikunshenxi Capsule, Shenyankangfu Tablet, Uremic Clearance Granule, Yinhuamiyangling and Others......17
Table 15: Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......18
Table 16: Chronic Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......19
Table 17: New Patients with Kidney Failure by Cause in the US (2015) - Percentage Share Breakdown by Volume for Diabetes, High Blood Pressure and Others......20
Gastrointestinal Drugs......21
Table 18: Gastrointestinal Market Worldwide (2015) in US$ Million......21
Table 19: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......22
Biopharmaceuticals......23
Table 20: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......23
Table 21: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......24
Dialysis......25
Table 22: Market Shares of Leading Dialysis Service Providers Worldwide (2015) - Percentage Share Breakdown by Value for Fresenius SE & Co. KGaA, DaVita Healthcare Partners, Inc. and Others......25
Gastrointestinal Drugs......26
Table 23: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Others......26
Table 24: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......27
Table 25: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over- the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......28
Table 26: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......29
Table 27: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......30
Phosphate Binder Drugs......31
Table 28: Market Shares of Leading Phosphate Binder Drugs for Treatment of Hyperkalemia and Hyperphosphatemia Worldwide (2015) - Percentage Share Breakdown by Value for Calcium Acetate, Sevelamer and Others......31